Higher IGF-1 and IGFBP-3 levels in CC genotype carriers could indicate enhanced tumorigenic pathways mediated through IGF signalling, potentially influencing breast cancer susceptibility and progression. The gene discussed is IGFBP3; the disease is breast carcinoma.